Xi S, Grandis J R
Department of Otolaryngology, University of Pittsburgh School of Medicine, PA, USA.
J Dent Res. 2003 Jan;82(1):11-6. doi: 10.1177/154405910308200104.
Despite advances in surgery, radiotherapy, and chemotherapy, the survival of patients with oral squamous cell carcinoma has not significantly improved over the past several decades. Treatment options for recurrent or refractory oral cancers are limited. Gene therapy for oral cancer is currently under investigation in clinical trials. The goal of cancer gene therapy is to introduce new genetic material into target cells without toxicity to non-target tissues. This review discusses the techniques used in cancer gene therapy for oral squamous cell carcinoma and summarizes the ongoing strategies that are being evaluated in clinical trials.
尽管在手术、放疗和化疗方面取得了进展,但在过去几十年里,口腔鳞状细胞癌患者的生存率并未显著提高。复发性或难治性口腔癌的治疗选择有限。口腔癌的基因治疗目前正在临床试验中进行研究。癌症基因治疗的目标是将新的遗传物质导入靶细胞,而不对非靶组织产生毒性。本文综述了口腔鳞状细胞癌基因治疗中使用的技术,并总结了正在临床试验中评估的现有策略。